Healthcare

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer

SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free survival at primary analysis and...

Exoskeleton Market to Surpass USD 23.6 Billion Valuation by 2031 On the Back of Rising Use of Exoskeletons in Healthcare and Industrial Applications | SkyQuest Technology

WESTFORD, Mass., July 3, 2024 /PRNewswire/ -- According to SkyQuest, the global Exoskeleton Market size was valued at USD 1.58 Billion...

error: Content is protected !!